|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 February 2001, Vol. 97, No. 4, pp. 1027-1034
IMMUNOBIOLOGY
Cell-surface trafficking and release of flt3 ligand from T
lymphocytes is induced by common cytokine receptor  -chain signaling
and inhibited by cyclosporin A
Elena Chklovskaia,
Catherine Nissen,
Lukas Landmann,
Christoph Rahner,
Otmar Pfister, and
Aleksandra Wodnar-Filipowicz
From the Department of Research, University Hospital
Basel, and Institute of Anatomy, University of Basel, Basel,
Switzerland.
The flt3 ligand (FL) is a growth and differentiation factor for
primitive hematopoietic precursors, dendritic cells, and natural killer
cells. Human T lymphocytes express FL constitutively, but the cytokine
is retained intracellularly within the Golgi complex. FL is mobilized
from the cytoplasmic stores and its serum levels are massively
increased during the period of bone marrow aplasia after stem cell
transplantation (SCT). Signals that trigger the release of FL by T
cells remain unknown. This study shows that interleukin (IL)-2, IL-4,
IL-7, and IL-15, acting through a common receptor  chain (c), but
not cytokines interacting with other receptor families, are efficient
inducers of cell surface expression of membrane-bound FL (mFL) and
secretion of soluble FL (sFL) by human peripheral blood T lymphocytes.
The c-mediated signaling up-regulated FL in a T-cell
receptor-independent manner. IL-2 and IL-7 stimulated both FL messenger
RNA (mRNA) expression and translocation of FL protein to the cell
surface. Cyclosporin A (CsA) inhibited c-mediated trafficking of FL
at the level of transition from the Golgi to the trans-Golgi network.
Accordingly, serum levels of sFL and expression of mFL by T cells of
CsA-treated recipients of stem cell allografts were reduced
approximately 2-fold (P < .01) compared to patients
receiving autologous grafts. The conclusion is that FL expression is
controlled by c receptor signaling and that CsA interferes with FL
release by T cells. The link between c-dependent T-cell activation
and FL expression might be important for T-cell effector functions in
graft acceptance and antitumor immunity after SCT.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
K. Horiuchi, H. Morioka, H. Takaishi, H. Akiyama, C. P. Blobel, and Y. Toyama
Ectodomain Shedding of FLT3 Ligand Is Mediated by TNF-{alpha} Converting Enzyme
J. Immunol.,
June 15, 2009;
182(12):
7408 - 7414.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Buza-Vidas, M. Cheng, S. Duarte, H. Nozad Charoudeh, S. E. W. Jacobsen, and E. Sitnicka
FLT3 receptor and ligand are dispensable for maintenance and posttransplantation expansion of mouse hematopoietic stem cells
Blood,
April 9, 2009;
113(15):
3453 - 3460.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Bridenbaugh, L. Kenins, E. Bouliong-Pillai, C. P. Kalberer, E. Shklovskaya, A. Gratwohl, and A. Wodnar-Filipowicz
Clinical stem-cell sources contain CD8+CD3+ T-cell receptor-negative cells that facilitate bone marrow repopulation with hematopoietic stem cells
Blood,
February 1, 2008;
111(3):
1735 - 1738.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Sun, H. Wei, R. Sun, W. Xiao, Y. Yang, and Z. Tian
Human Interleukin-15 Improves Engraftment of Human T Cells in NOD-SCID Mice
Clin. Vaccine Immunol.,
February 1, 2006;
13(2):
227 - 234.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Pushkarsky, V. Yurchenko, C. Vanpouille, B. Brichacek, I. Vaisman, S. Hatakeyama, K. I. Nakayama, B. Sherry, and M. I. Bukrinsky
Cell Surface Expression of CD147/EMMPRIN Is Regulated by Cyclophilin 60
J. Biol. Chem.,
July 29, 2005;
280(30):
27866 - 27871.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Yurchenko, T. Pushkarsky, J.-H. Li, W. W. Dai, B. Sherry, and M. Bukrinsky
Regulation of CD147 Cell Surface Expression: INVOLVEMENT OF THE PROLINE RESIDUE IN THE CD147 TRANSMEMBRANE DOMAIN
J. Biol. Chem.,
April 29, 2005;
280(17):
17013 - 17019.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Franchini, H. Hefti, S. Vollstedt, B. Glanzmann, M. Riesen, M. Ackermann, P. Chaplin, K. Shortman, and M. Suter
Dendritic Cells from Mice Neonatally Vaccinated with Modified Vaccinia Virus Ankara Transfer Resistance against Herpes Simplex Virus Type I to Naive One-Week-Old Mice
J. Immunol.,
May 15, 2004;
172(10):
6304 - 6312.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Chklovskaia, P. Nowbakht, C. Nissen, A. Gratwohl, M. Bargetzi, and A. Wodnar-Filipowicz
Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: effects of endogenous flt3 ligand
Blood,
May 15, 2004;
103(10):
3860 - 3868.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Wodnar-Filipowicz
Flt3 Ligand: Role in Control of Hematopoietic and Immune Functions of the Bone Marrow
Physiology,
December 1, 2003;
18(6):
247 - 251.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. P. Kalberer, U. Siegler, and A. Wodnar-Filipowicz
Human NK cell development in NOD/SCID mice receiving grafts of cord blood CD34+ cells
Blood,
July 1, 2003;
102(1):
127 - 135.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R. Comeau, A.-R. Van der Vuurst de Vries, C. R. Maliszewski, and L. Galibert
CD123bright Plasmacytoid Predendritic Cells: Progenitors Undergoing Cell Fate Conversion?
J. Immunol.,
July 1, 2002;
169(1):
75 - 83.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
